ArticleMedicina (Kaunas, Lithuania)2025
Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal Cancer.
Ayberk Bayramgil, Ahmet Bilici, Ali Murat Tatlı, Seda Kahraman, Yunus Emre Altintas, Fahri Akgul, Musa Barış Aykan, Jamshid Hamdard, Sema Sezgin Göksu, Mehmet Ali Nahit Şendur and 2 more
Abstract readComparative Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Ayberk BayramgilDepartment of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, 34000 İstanbul, Türkiye.ORCID 0000-0003-1782-7808 Ahmet BiliciDepartment of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, 34000 İstanbul, Türkiye.ORCID 0000-0002-0443-6966 Ali Murat TatlıDepartment of Medical Oncology, Faculty of Medicine, Akdeniz University, 07000 Antalya, Türkiye.
Seda KahramanDepartment of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, 06000 Ankara, Türkiye.
Yunus Emre AltintasDepartment of Medical Oncology, Faculty of Medicine, Koc University, 34000 İstanbul, Türkiye.ORCID 0000-0002-0634-7350 Fahri AkgulDepartment of Medical Oncology, Faculty of Medicine, Trakya University, 22020 Edirne, Türkiye.
Musa Barış AykanDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, 06000 Ankara, Türkiye.ORCID 0000-0001-7538-9119 Jamshid HamdardDepartment of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, 34000 İstanbul, Türkiye.ORCID 0000-0002-5823-1704 Sema Sezgin GöksuDepartment of Medical Oncology, Faculty of Medicine, Akdeniz University, 07000 Antalya, Türkiye.
Mehmet Ali Nahit ŞendurDepartment of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, 06000 Ankara, Türkiye.ORCID 0000-0001-7021-6139 Fatih SelçukbiricikDepartment of Medical Oncology, Faculty of Medicine, Koc University, 34000 İstanbul, Türkiye.
Ömer Fatih ÖlmezDepartment of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, 34000 İstanbul, Türkiye.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Neoadjuvant TherapyRectal NeoplasmsAdultAgedDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesTreatment OutcomeTurkeycolorectal cancerlocally advanced rectal cancerneoadjuvant therapypathological complete responsestandard neoadjuvant therapytotal neoadjuvant therapy
Identifiers
PMID40005456
PMCPMC11857647
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390